Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia

BACKGROUND AND OBJECTIVE: Blockade of immune checkpoint receptors in the treatment of cancers has been mentioned in several studies. Here, we investigated the efficacy of combined blockade of two inhibitory receptors, PD-1 and TIGIT, in restoring functional features of CD8+ T-cells in CLL. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatefi, Fatemeh, Asgarian-Omran, Hossein, Hossein-Nattaj, Hadi, Akbar, Armin, Shekarriz, Ramin, Zaboli, Ehsan, Janbabaei, Ghasem, Tehrani, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727349/
https://www.ncbi.nlm.nih.gov/pubmed/35901326
http://dx.doi.org/10.31557/APJCP.2022.23.7.2225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727349/
https://www.ncbi.nlm.nih.gov/pubmed/35901326
http://dx.doi.org/10.31557/APJCP.2022.23.7.2225

Ejemplares similares